You are here

Article Text

Article menu

See original article:

Download PDFPDF

Correction
Correction
Free

https://doi.org/10.1136/bmjopen-2014-006816corr1

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Lexchin J. Health Canada's use of its priority review process for new drugs: a cohort study. BMJ Open 2015;5:e006816.

    The WHO ATC database was used to determine first-in-class status on the mistaken information that a first in class drug ended in a 01 number. After the paper was published the author was informed that this assumption was incorrect. Therefore, information from the United States Food and Drug Administration (contained in the new reference 10) was used instead to determine which drugs were first-in-class. The results from this reanalysis are quite similar and do not change the conclusions in the article.

    Abstract – Data sources

    Original: “World Health Organization Collaborating Centre for Drug …

    View Full Text

    Linked Articles